94453 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems; Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2 Oxygen atoms
Dipeptidyl peptidase inhibitors
#302Benzimidazol-2-one derivatives and their use
#303Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
#304Diketopyrrolopyrrole pigments
#305Non-imidazole aryloxypiperidines
#306Phenethanolamine derivatives for treatment of respiratory diseases
#307Preventives/remedies for urinary disturbance
#308Serotonergic 5HTreceptor compounds for treating ocular and CNS disorders
#309Ophthalmic compositions for treating ocular hypertension
#310Nociceptin analogs
#311Use of a polymorph of flibanserin for treating disease
#3121-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
#313Benzimidazole derivatives, their production and use
#314Benzylether amine compounds useful as CCR-5 antagonists
#315Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
#316Novel compounds
#317Compositions and methods for the treatment of disease associated with Trp-p8 expression
#318LTA4H Modulators
#319LTA4H modulators
#320Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
#321Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands
#322Benzimidazole compounds
#3232-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as βagonists
#324Modulators of VR1 receptor
#325Compounds, compositions and methods for crop enhancement